1. Home
  2. AMR vs NTLA Comparison

AMR vs NTLA Comparison

Compare AMR & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMR
  • NTLA
  • Stock Information
  • Founded
  • AMR 2016
  • NTLA 2014
  • Country
  • AMR United States
  • NTLA United States
  • Employees
  • AMR N/A
  • NTLA N/A
  • Industry
  • AMR Coal Mining
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • AMR Energy
  • NTLA Health Care
  • Exchange
  • AMR Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • AMR 1.5B
  • NTLA 1.2B
  • IPO Year
  • AMR N/A
  • NTLA 2016
  • Fundamental
  • Price
  • AMR $134.42
  • NTLA $13.60
  • Analyst Decision
  • AMR Buy
  • NTLA Buy
  • Analyst Count
  • AMR 3
  • NTLA 19
  • Target Price
  • AMR $141.50
  • NTLA $35.11
  • AVG Volume (30 Days)
  • AMR 461.3K
  • NTLA 4.7M
  • Earning Date
  • AMR 08-08-2025
  • NTLA 08-07-2025
  • Dividend Yield
  • AMR N/A
  • NTLA N/A
  • EPS Growth
  • AMR N/A
  • NTLA N/A
  • EPS
  • AMR 2.04
  • NTLA N/A
  • Revenue
  • AMR $2,625,170,000.00
  • NTLA $45,569,000.00
  • Revenue This Year
  • AMR N/A
  • NTLA N/A
  • Revenue Next Year
  • AMR $21.82
  • NTLA N/A
  • P/E Ratio
  • AMR $65.83
  • NTLA N/A
  • Revenue Growth
  • AMR N/A
  • NTLA N/A
  • 52 Week Low
  • AMR $97.41
  • NTLA $5.90
  • 52 Week High
  • AMR $303.41
  • NTLA $27.42
  • Technical
  • Relative Strength Index (RSI)
  • AMR 61.71
  • NTLA 65.69
  • Support Level
  • AMR $113.78
  • NTLA $12.48
  • Resistance Level
  • AMR $145.42
  • NTLA $14.61
  • Average True Range (ATR)
  • AMR 7.02
  • NTLA 0.90
  • MACD
  • AMR 2.44
  • NTLA 0.13
  • Stochastic Oscillator
  • AMR 69.62
  • NTLA 76.33

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: